Haemonetics (HAE) Competitors $75.44 -1.46 (-1.90%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends HAE vs. MMSI, XRAY, ICUI, QDEL, NEOG, STAA, CERS, OSUR, ANIK, and UTMDShould you be buying Haemonetics stock or one of its competitors? The main competitors of Haemonetics include Merit Medical Systems (MMSI), DENTSPLY SIRONA (XRAY), ICU Medical (ICUI), QuidelOrtho (QDEL), Neogen (NEOG), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), and Utah Medical Products (UTMD). These companies are all part of the "health care supplies" industry. Haemonetics vs. Merit Medical Systems DENTSPLY SIRONA ICU Medical QuidelOrtho Neogen STAAR Surgical Cerus OraSure Technologies Anika Therapeutics Utah Medical Products Merit Medical Systems (NASDAQ:MMSI) and Haemonetics (NYSE:HAE) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends, media sentiment, valuation and community ranking. Which has preferable valuation and earnings, MMSI or HAE? Haemonetics has higher revenue and earnings than Merit Medical Systems. Haemonetics is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMerit Medical Systems$1.26B4.55$94.41M$2.0448.15Haemonetics$1.36B2.78$117.56M$2.4131.30 Do analysts recommend MMSI or HAE? Merit Medical Systems currently has a consensus target price of $105.60, indicating a potential upside of 7.51%. Haemonetics has a consensus target price of $108.78, indicating a potential upside of 44.19%. Given Haemonetics' higher probable upside, analysts clearly believe Haemonetics is more favorable than Merit Medical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Merit Medical Systems 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 3.00Haemonetics 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.89 Does the MarketBeat Community favor MMSI or HAE? Merit Medical Systems received 39 more outperform votes than Haemonetics when rated by MarketBeat users. Likewise, 69.33% of users gave Merit Medical Systems an outperform vote while only 61.43% of users gave Haemonetics an outperform vote. CompanyUnderperformOutperformMerit Medical SystemsOutperform Votes43469.33% Underperform Votes19230.67% HaemoneticsOutperform Votes39561.43% Underperform Votes24838.57% Which has more risk and volatility, MMSI or HAE? Merit Medical Systems has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500. Comparatively, Haemonetics has a beta of 0.38, suggesting that its share price is 62% less volatile than the S&P 500. Does the media prefer MMSI or HAE? In the previous week, Merit Medical Systems had 16 more articles in the media than Haemonetics. MarketBeat recorded 20 mentions for Merit Medical Systems and 4 mentions for Haemonetics. Merit Medical Systems' average media sentiment score of 0.95 beat Haemonetics' score of 0.92 indicating that Merit Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Merit Medical Systems 8 Very Positive mention(s) 7 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Haemonetics 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is MMSI or HAE more profitable? Haemonetics has a net margin of 9.10% compared to Merit Medical Systems' net margin of 9.05%. Haemonetics' return on equity of 22.67% beat Merit Medical Systems' return on equity.Company Net Margins Return on Equity Return on Assets Merit Medical Systems9.05% 15.61% 8.38% Haemonetics 9.10%22.67%8.83% Do insiders & institutionals believe in MMSI or HAE? 99.7% of Merit Medical Systems shares are held by institutional investors. Comparatively, 99.7% of Haemonetics shares are held by institutional investors. 3.7% of Merit Medical Systems shares are held by company insiders. Comparatively, 1.8% of Haemonetics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryMerit Medical Systems beats Haemonetics on 10 of the 18 factors compared between the two stocks. Ad Weiss RatingsBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $125,000 by the end of his first month in office.This could be his favorite coin. Get Haemonetics News Delivered to You Automatically Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HAE vs. The Competition Export to ExcelMetricHaemoneticsSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$3.79B$4.34B$5.12B$19.18BDividend YieldN/A41.46%4.91%3.60%P/E Ratio31.3025.3791.3441.28Price / Sales2.7845.961,117.7017.60Price / Cash13.7743.4542.6421.28Price / Book3.997.364.795.32Net Income$117.56M$13.64M$120.07M$989.88M7 Day Performance-7.08%-2.80%-1.90%-3.54%1 Month Performance-11.69%0.56%11.45%-3.68%1 Year Performance-11.78%41.87%30.63%12.14% Haemonetics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HAEHaemonetics4.5851 of 5 stars$75.44-1.9%$108.78+44.2%-12.5%$3.79B$1.36B31.303,657Positive NewsHigh Trading VolumeMMSIMerit Medical Systems4.4681 of 5 stars$102.86+0.1%$105.09+2.2%+37.0%$5.99B$1.33B50.476,950News CoverageXRAYDENTSPLY SIRONA4.8879 of 5 stars$19.99+1.4%$28.40+42.1%-45.0%$3.97B$3.90B-9.5315,000Analyst ForecastICUIICU Medical4.585 of 5 stars$160.76-0.5%$199.67+24.2%+61.3%$3.94B$2.34B-35.3714,000QDELQuidelOrtho4.1214 of 5 stars$42.67+3.2%$53.43+25.2%-36.8%$2.87B$3.00B-1.577,100Gap UpNEOGNeogen3.4609 of 5 stars$11.96-1.6%$17.50+46.3%-39.8%$2.59B$912.20M-110.452,640Analyst ForecastNews CoverageSTAASTAAR Surgical4.8226 of 5 stars$24.39-1.9%$42.83+75.6%-19.9%$1.20B$322.42M56.501,115Insider TradeCERSCerus2.8128 of 5 stars$1.81+5.6%$3.63+100.8%-25.1%$335.22M$176.23M-15.55625OSUROraSure Technologies4.3598 of 5 stars$4.03+3.1%$5.50+36.5%-53.6%$300.61M$224.26M27.60638News CoverageGap DownANIKAnika Therapeutics4.1654 of 5 stars$17.20+0.2%$24.50+42.4%-26.8%$251.91M$164.17M-2.58357Positive NewsUTMDUtah Medical Products3.1165 of 5 stars$62.95+0.5%N/A-27.9%$213.40M$50.22M14.73180Positive News Related Companies and Tools Related Companies Merit Medical Systems Alternatives DENTSPLY SIRONA Alternatives ICU Medical Alternatives QuidelOrtho Alternatives Neogen Alternatives STAAR Surgical Alternatives Cerus Alternatives OraSure Technologies Alternatives Anika Therapeutics Alternatives Utah Medical Products Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:HAE) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haemonetics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Haemonetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
